Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Marburg Ion Beam Therapy Center (MIT) is a specialized medical facility in Germany that provides advanced particle therapy for cancer treatment. It is one of the few centers worldwide offering both proton and carbon ion therapy, which allows for extremely precise targeting of tumors while minimizing radiation exposure to surrounding healthy organs. This technology is particularly beneficial for treating deep-seated or radioresistant tumors, such as those in the brain, skull base, or prostate. MIT is operated as a joint venture between the University Hospital of Heidelberg and the University Hospital of Giessen and Marburg. Since its clinical launch in 2015, the center has integrated high-end medical technology with academic research to improve outcomes for complex oncological cases. The facility serves as a major European hub for clinical trials and innovative radiotherapy techniques.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Marburg Ion Beam Therapy Center.